Epithelial-to-mesenchymal transition (EMT) is a process that provides cancer cells with a metastatic phenotype characterized by the loss of the epithelial phenotype and E-cadherin down-regulation, playing a key role in the progression, metastasis and chemoresistance. This evidence concerns the gene CDH1 and cancer.